Movement Alert|Calumet Specialty Products Partners LP falls 5.25% in Regular Trading, post-earnings pullback emerges after recent Q3-driven rally

Market Focus11-13

On November 13, Calumet Specialty Products Partners LP fell 5.25% in Regular Trading, trading at $34.35, with turnover of $4.377 million.

The move follows a recent earnings-driven rally and appears tied to a post-results pullback as the market digests a strong third-quarter beat alongside remaining debate over profitability durability and deleveraging execution.

Earlier, the company reported third-quarter EPS of $2.91, well above consensus estimates of about $1.59 to $1.63, on revenue of about $1.682 billion versus expectations near $1.344 billion. Adjusted EBITDA rose to roughly $322 million from $69.6 million a year earlier, while management said it had repaid about $265 million of debt since July and continues advancing the MaxSAF expansion plan. At the same time, recent market commentary noted quarterly profit was below the prior year level and the company remained in a net loss position for the first nine months, factors that may be contributing to near-term profit-taking after the initial upside reaction.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment